Stocks Health care XNCR

NASDAQ · Health care

Xencor Inc (XNCR)

Xencor Inc brought in $105M of revenue over the twelve months to June 30, 2026, down 28.6% from a year earlier. It posted a net loss of $163.3M. In fiscal 2025 capital spending exceeded operating cash flow by $138.3M. At June 30, 2026 it held $44.7M in cash against $77.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

What Xencor Inc does

Xencor Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker XNCR.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where XNCR ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Xencor Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 5, 2026
   Quarterly report 10-Q · period to June 30, 2026
2. August 5, 2026
   Quarterly results 8-K
3. July 31, 2026
   Passive stake (5% or more) SCHEDULE 13G
4. July 29, 2026
   Quarterly results 8-K
5. June 18, 2026
   Shareholder vote results 8-K
6. May 15, 2026
   Passive stake changed SCHEDULE 13G/A
7. May 6, 2026
   Quarterly report 10-Q · period to March 31, 2026
8. May 6, 2026
   Quarterly results 8-K
9. May 5, 2026
   Investor disclosure 8-K
10. April 27, 2026
    Annual report to shareholders ARS

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 8, 2026. Insider transactions on SEC

Insider trades

What the people running Xencor Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about XNCR

What does Xencor Inc do?

Xencor Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker XNCR.

Is Xencor Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $163.3M on revenue of $105M.

How much revenue does Xencor Inc make?

Over the twelve months to June 30, 2026 Xencor Inc reported revenue of $105M. That is 28.6% less than a year earlier.

When did Xencor Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026.

Similar companies

Compare XNCR with

Compare XNCR with any company

Follow XNCR

Get an email when Xencor Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow XNCR: get an email when it files

Where the numbers come from

Financial figures are the values Xencor Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.